|
?:abstract
|
-
Background: COVID-19 pneumonia is a newly recognized illness that is spreading rapidly around the world and causes many disability and deaths Some diseases, for instance diabetes, is continuously suggested as a risk factor which contributes to the severity and mortality of COVID-19 However, to date, there are no comprehensive studies aiming to explain the exact relationship between diabetes and COVID-19 Thus, this study aims to summarize the evidence about diabetes and COVID-19 outbreak through a systematic review and meta-analysis approach Method: A literature review was implemented within databases of Scopus, PubMed, Science direct, and Web of science Observational reviews, case-report, and case-series studies that assessed the diabetes in COVID-19 patients, were included Data extraction and assessment were guided by PRISMA checklist Findings: Some studies suggest that there were no significant differences in symptoms between patients who suffered from both diabetes and COVID-19 and those who only suffered COVID-19 In the subsequent meta-analysis 14 5% of the subjects were diabetic patient These clients have poor ARDS prognosis, severe symptoms, and the death rate is higher among COVID-19 patients In addition, it is suggested the diabetic patients will be treated with antibiotics, antivirals, and HCQ
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}